PPTA Data Program
In collaboration with industry regulators and stakeholders, PPTA has developed a system that we believe is the best way to present the distribution of core plasma protein therapies in Europe. The PPTA Data Program is a voluntary manufacturer initiative undertaken in response to drug shortage concerns, and is intended to provide a reliable, country-by-country assessment of the availability of these life-saving therapies.
PPTA’s Web-based system provides aggregate, monthly distribution data for the following categories of plasma protein therapies:
- Albumin ≤ 5%
- Albumin 20% - 25%
- Intravenous Immune Globulin (IVIG)
- Subcutaneous and Intra-Muscular Immune Globulin (SC/IM IG)
- Plasma-Derived Factor VIII
- Recombinant Factor VIII
- Plasma-Derived Factor IX
* For some countries there is no reportable data available per SOPs.